Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia: implications for anticancer therapies.
暂无分享,去创建一个
V. Grégoire | O. Feron | C. Dessy | C. Bouzin | C. Michiels | J. Saliez | P. Martinive | F. Defresne | F. Lair | O. Féron | Julie Saliez
[1] Bruce Klitzman,et al. Direct demonstration of instabilities in oxygen concentrations within the extravascular compartment of an experimental tumor. , 2006, Cancer research.
[2] Bernard Gallez,et al. The role of vessel maturation and vessel functionality in spontaneous fluctuations of T2*‐weighted GRE signal within tumors , 2006, NMR in biomedicine.
[3] E. Rofstad,et al. Fluctuations in pO2 in poorly and well-oxygenated spontaneous canine tumors before and during fractionated radiation therapy. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[4] M. Dewhirst,et al. Hyperspectral imaging of hemoglobin saturation in tumor microvasculature and tumor hypoxia development. , 2005, Journal of biomedical optics.
[5] O. Feron,et al. Antitumor effects of in vivo caveolin gene delivery are associated with the inhibition of the proangiogenic and vasodilatory effects of nitric oxide , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[6] M. Dewhirst,et al. Enhancement of Hypoxia-Induced Tumor Cell Death In vitro and Radiation Therapy In vivo by Use of Small Interfering RNA Targeted to Hypoxia-Inducible Factor-1α , 2004, Cancer Research.
[7] R. Gillies,et al. Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.
[8] O. Féron. Targeting the tumor vascular compartment to improve conventional cancer therapy. , 2004, Trends in pharmacological sciences.
[9] K. Bennewith,et al. Quantifying Transient Hypoxia in Human Tumor Xenografts by Flow Cytometry , 2004, Cancer Research.
[10] Benoit Macq,et al. Physiological noise in murine solid tumours using T2*-weighted gradient-echo imaging: a marker of tumour acute hypoxia? , 2004, Physics in medicine and biology.
[11] Jean-Luc Balligand,et al. Caveolin-1 Expression Is Critical for Vascular Endothelial Growth Factor–Induced Ischemic Hindlimb Collateralization and Nitric Oxide–Mediated Angiogenesis , 2004, Circulation research.
[12] M. Dewhirst,et al. Predicting the effect of temporal variations in PO2 on tumor radiosensitivity. , 2004, International journal of radiation oncology, biology, physics.
[13] M. Dewhirst,et al. The relationship between hypoxia and angiogenesis. , 2004, Seminars in radiation oncology.
[14] M. Dewhirst,et al. Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules. , 2004, Cancer cell.
[15] Richard P. Hill,et al. Acute Hypoxia Enhances Spontaneous Lymph Node Metastasis in an Orthotopic Murine Model of Human Cervical Carcinoma , 2004, Cancer Research.
[16] R. Durand. Intermittent Blood Flow in Solid Tumours – an under-appreciated Source of ‘drug Resistance’ , 2004, Cancer and Metastasis Reviews.
[17] Richard P. Hill,et al. The hypoxic tumour microenvironment and metastatic progression , 2004, Clinical & Experimental Metastasis.
[18] Christian Frelin,et al. Hypoxia Up-regulates Prolyl Hydroxylase Activity , 2003, Journal of Biological Chemistry.
[19] G. Semenza. Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.
[20] Timothy W Secomb,et al. Effect of longitudinal oxygen gradients on effectiveness of manipulation of tumor oxygenation. , 2003, Cancer research.
[21] E. Rofstad,et al. Temporal heterogeneity in oxygen tension in human melanoma xenografts , 2003, British Journal of Cancer.
[22] Rakesh K Jain,et al. Molecular regulation of vessel maturation , 2003, Nature Medicine.
[23] Jean-Luc Balligand,et al. Irradiation-induced angiogenesis through the up-regulation of the nitric oxide pathway: implications for tumor radiotherapy. , 2003, Cancer research.
[24] Mechanisms underlying hypoxia development in tumors. , 2003, Advances in experimental medicine and biology.
[25] Bernard Gallez,et al. How does blood oxygen level‐dependent (BOLD) contrast correlate with oxygen partial pressure (pO2) inside tumors? , 2002, Magnetic resonance in medicine.
[26] D. Mottet,et al. Site-directed mutagenesis studies of the hypoxia-inducible factor-1α DNA-binding domain , 2002 .
[27] Adrian L. Harris,et al. Hypoxia — a key regulatory factor in tumour growth , 2002, Nature Reviews Cancer.
[28] R. Hill,et al. Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors. , 2001, Cancer research.
[29] R. Jain,et al. Vascular Morphogenesis and Remodeling in a Human Tumor Xenograft: Blood Vessel Formation and Growth After Ovariectomy and Tumor Implantation , 2001, Circulation research.
[30] P. Vaupel,et al. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. , 2001, Journal of the National Cancer Institute.
[31] G M Tozer,et al. Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation. , 2000, European journal of cancer.
[32] E. Rofstad. Microenvironment-induced cancer metastasis , 2000, International journal of radiation biology.
[33] E. Rofstad,et al. Radiobiological and immunohistochemical assessment of hypoxia in human melanoma xenografts: acute and chronic hypoxia in individual tumours. , 1999, International journal of radiation biology.
[34] M. Dewhirst,et al. Fourier analysis of fluctuations of oxygen tension and blood flow in R3230Ac tumors and muscle in rats. , 1999, American journal of physiology. Heart and circulatory physiology.
[35] M. Neeman,et al. Dynamic remodeling of the vascular bed precedes tumor growth: MLS ovarian carcinoma spheroids implanted in nude mice. , 1999, Neoplasia.
[36] M. Dewhirst,et al. Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. , 1996, Cancer research.
[37] M. Dewhirst,et al. Microvascular studies on the origins of perfusion-limited hypoxia. , 1996, The British journal of cancer. Supplement.
[38] M. Dewhirst,et al. Tumor oxygenation: a matter of supply and demand. , 1996, Anticancer research.
[39] S. Hill,et al. Temporal heterogeneity in microregional erythrocyte flux in experimental solid tumours. , 1995, British Journal of Cancer.
[40] G. Cokelet,et al. Fluctuations in microvascular blood flow parameters caused by hemodynamic mechanisms. , 1994, The American journal of physiology.
[41] M. Dewhirst,et al. Perivascular oxygen tensions in a transplantable mammary tumor growing in a dorsal flap window chamber. , 1992, Radiation research.
[42] C. Coleman,et al. Hypoxia in tumors: a paradigm for the approach to biochemical and physiologic heterogeneity. , 1988, Journal of the National Cancer Institute.
[43] D. Chaplin,et al. Intermittent blood flow in a murine tumor: radiobiological effects. , 1987, Cancer research.
[44] J. Gross,et al. Dynamics of microvascular flow in implanted mouse mammary tumours. , 1977, Bibliotheca anatomica.
[45] H. Taper,et al. A new transplantable mouse liver tumor of spontaneous origin. , 1966, Cancer research.